Home/Filings/4/0001209191-23-011110
4//SEC Filing

Dhanak Dashyant 4

Accession 0001209191-23-011110

CIK 0000879169other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:00 PM ET

Size

7.5 KB

Accession

0001209191-23-011110

Insider Transaction Report

Form 4
Period: 2023-02-16
Dhanak Dashyant
EVP & Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-16$65.42/sh+3,693$241,59656,956 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2023-02-163,6930 total
    Exercise: $65.42Exp: 2028-12-10Common Stock (3,693 underlying)
Footnotes (2)
  • [F1]This includes an aggregate of 41,531 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
  • [F2]Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0001760682

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:00 PM ET
Size
7.5 KB